Works matching AU Aasly, J. O.

Results: 9
    1

    Death-associated protein kinase 1 variation and Parkinson's disease.

    Published in:
    European Journal of Neurology, 2011, v. 18, n. 8, p. 1090, doi. 10.1111/j.1468-1331.2010.03255.x
    By:
    • Dachsel, J. C.;
    • Wider, C.;
    • Vilariño-Güell, C.;
    • Aasly, J. O.;
    • Rajput, A.;
    • Rajput, A. H.;
    • Lynch, T.;
    • Craig, D.;
    • Krygowska-Wajs, A.;
    • Jasinska-Myga, B.;
    • Opala, G.;
    • Barcikowska, M.;
    • Czyzewski, K.;
    • Wu, R. -M.;
    • Heckman, M. G.;
    • Uitti, R. J.;
    • Wszolek, Z. K.;
    • Farrer, M. J.;
    • Ross, O. A.
    Publication type:
    Article
    2

    SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

    Published in:
    European Journal of Neurology, 2011, v. 18, n. 6, p. 876, doi. 10.1111/j.1468-1331.2010.03297.x
    By:
    • Wider, C.;
    • Vilariño-Güell, C.;
    • Heckman, M. G.;
    • Jasinska-Myga, B.;
    • Ortolaza-Soto, A. I.;
    • Diehl, N. N.;
    • Crook, J. E.;
    • Cobb, S. A.;
    • Bacon, J. A.;
    • Aasly, J. O.;
    • Gibson, J. M.;
    • Lynch, T.;
    • Uitti, R. J.;
    • Wszolek, Z. K.;
    • Farrer, M. J.;
    • Ross, O. A.
    Publication type:
    Article
    3

    Association of the MAPT locus with Parkinson’s disease.

    Published in:
    European Journal of Neurology, 2010, v. 17, n. 3, p. 483, doi. 10.1111/j.1468-1331.2009.02847.x
    By:
    • Wider, C.;
    • Vilariño-Güell, C.;
    • Jasinska-Myga, B.;
    • Heckman, M. G.;
    • Soto-Ortolaza, A. I.;
    • Cobb, S. A.;
    • Aasly, J. O.;
    • Gibson, J. M.;
    • Lynch, T.;
    • Uitti, R. J.;
    • Wszolek, Z. K.;
    • Farrer, M. J.;
    • Ross, O. A.
    Publication type:
    Article
    4

    Calbindin-1 association and Parkinson’s disease.

    Published in:
    European Journal of Neurology, 2010, v. 17, n. 2, p. 208, doi. 10.1111/j.1468-1331.2009.02769.x
    By:
    • Soto-Ortolaza, A. I.;
    • Behrouz, B.;
    • Wider, C.;
    • Vilariño-Güell, C.;
    • Heckman, M. G.;
    • Aasly, J. O.;
    • Mark Gibson, J.;
    • Lynch, T.;
    • Jasinska-Myga, B.;
    • Krygowska-Wajs, A.;
    • Opala, G.;
    • Barcikowska, M.;
    • Czyzewski, K.;
    • Uitti, R. J.;
    • Wszolek, Z. K.;
    • Farrer, M. J.;
    • Ross, O. A.
    Publication type:
    Article
    5

    LRRK2 and Parkinson’s disease in Norway.

    Published in:
    Acta Neurologica Scandinavica: Supplementum, 2007, v. 115, p. 72, doi. 10.1111/j.1600-0404.2007.00852.x
    By:
    • Toft, M.;
    • Haugarvoll, K.;
    • Ross, O. A.;
    • Farrer, M. J.;
    • Aasly, J. O.
    Publication type:
    Article
    6

    Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.

    Published in:
    European Journal of Neurology, 2017, v. 24, n. 2, p. 427, doi. 10.1111/ene.13223
    By:
    • Brockmann, K.;
    • Schulte, C.;
    • Schneiderhan ‐ Marra, N.;
    • Apel, A.;
    • Pont ‐ Sunyer, C.;
    • Vilas, D.;
    • Ruiz ‐ Martinez, J.;
    • Langkamp, M.;
    • Corvol, J. ‐ C.;
    • Cormier, F.;
    • Knorpp, T.;
    • Joos, T. O.;
    • Bernard, A.;
    • Gasser, T.;
    • Marras, C.;
    • Schüle, B.;
    • Aasly, J. O.;
    • Foroud, T.;
    • Marti ‐ Masso, J. F.;
    • Brice, A.
    Publication type:
    Article
    7
    8
    9